IBB
- iShares Biotechnology ETFInformazioni chiave
| Data più antica | 2001-02-12 |
Informazioni ETF
| Emittente del fondo | BlackRock |
| Indice | ICE Biotechnology Index |
| Commissione di gestione | 0.45% |
| Numero di titoli in portafoglio | 211 |
| Data di lancio | 2001-02-05 |
| Classe di asset | Equity |
| Valuta | USD |
| Quotazione | US-listed |
| Settore | Healthcare |
| Stile di investimento | Growth |
| Senza leva finanziaria | Non-leveraged |
Informazioni su IBB
The iShares Biotechnology ETF provides exposure to the biotechnology sub-sector of the health care industry, investing in a diversified portfolio of over 200 stocks. The fund focuses on U.S. biotechnology companies, with a smaller allocation to international firms, and employs a tiered weighting scheme. It offers a multi-cap approach, investing in large, mid, and small-cap stocks, making it a comprehensive option for investors seeking biotech exposure.